[
  {
    "text": "1.\n              Curcio A, Torella D, Indolfi C (2011) Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy. Circ J. 75: 1287\u201396. \n                      Find this article online\n                    "
  }, 
  {
    "text": "2.\n              Wight TN (2008) Arterial remodeling in vascular disease: a key role for hyaluronan and versican. Front Biosci. 13: 4933\u20137. \n                      Find this article online\n                    "
  }, 
  {
    "text": "3.\n              Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, et al. (1999) Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem. 274: 25085\u201392. \n                      Find this article online\n                    "
  }, 
  {
    "text": "4.\n              Jiang D, Liang J, Noble PW (2011) Hyaluronan as an immune regulator in human diseases. Physiol Rev. 91: 221\u201364. \n                      Find this article online\n                    "
  }, 
  {
    "text": "5.\n              Stern R, Asari AA, Sugahara KN (2006) Hyaluronan fragments: an information-rich system. Eur J Cell Biol. 85: 699\u2013715. \n                      Find this article online\n                    "
  }, 
  {
    "text": "6.\n              Chai S, Chai Q, Danielsen CC, Hjorth P, Nyengaard JR, et al. (2005) Overexpression of hyaluronan in the tunica media promotes the development of atherosclerosis. Circ Res. 96: 583\u201391. \n                      Find this article online\n                    "
  }, 
  {
    "text": "7.\n              Nagy N, Freudenberger T, Melchior-Becker A, Rock K, Ter Braak M, et al. (2010) Inhibition of hyaluronan synthesis accelerates murine atherosclerosis: novel insights into the role of hyaluronan synthesis. Circulation. 122: 2313\u201322. \n                      Find this article online\n                    "
  }, 
  {
    "text": "8.\n              Riessen R, Wight TN, Pastore C, Henley C, Isner JM (1996) Distribution of hyaluronan during extracellular matrix remodeling in human restenotic arteries and balloon-injured rat carotid arteries. Circulation. 93: 1141\u20137. \n                      Find this article online\n                    "
  }, 
  {
    "text": "9.\n              Koyama H, Hibi T, Isogai Z, Yoneda M, Fujimori M, et al. (2007) Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M. Am J Pathol. 170: 1086\u201399. \n                      Find this article online\n                    "
  }, 
  {
    "text": "10.\n              Koyama H, Kobayashi N, Harada M, Takeoka M, Kawai Y, et al. (2008) Significance of tumor-associated stroma in promotion of intratumoral lymphangiogenesis: pivotal role of a hyaluronan-rich tumor microenvironment. Am J Pathol. 172: 179\u201393. \n                      Find this article online\n                    "
  }, 
  {
    "text": "11.\n              Holtwick R, Gotthardt M, Skryabin B, Steinmetz M, Potthast R, et al. (2002) Smooth muscle-selective deletion of guanylyl cyclase-A prevents the acute but not chronic effects of ANP on blood pressure. Proc Natl Acad Sci U S A. 99: 7142\u20137. \n                      Find this article online\n                    "
  }, 
  {
    "text": "12.\n              Miano JM, Ramanan N, Georger MA, de Mesy Bentley KL, Emerson RL, et al. (2004) Restricted inactivation of serum response factor to the cardiovascular system. Proc Natl Acad Sci U S A. 101: 17132\u20137. \n                      Find this article online\n                    "
  }, 
  {
    "text": "13.\n              Yajima N, Takahashi M, Morimoto H, Shiba Y, Takahashi Y, et al. (2008) Critical role of bone marrow apoptosis-associated speck-like protein, an inflammasome adaptor molecule, in neointimal formation after vascular injury in mice. Circulation. 117: 3079\u201387. \n                      Find this article online\n                    "
  }, 
  {
    "text": "14.\n              Sata M, Maejima Y, Adachi F, Fukino K, Saiura A, et al. (2000) A mouse model of vascular injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia. J Mol Cell Cardiol. 32: 2097\u2013104. \n                      Find this article online\n                    "
  }, 
  {
    "text": "15.\n              Tanaka K, Sata M, Hirata Y, Nagai R (2003) Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries. Circ Res. 93: 783\u201390. \n                      Find this article online\n                    "
  }, 
  {
    "text": "16.\n              Shiba Y, Takahashi M, Yoshioka T, Yajima N, Morimoto H, et al. (2007) M-CSF accelerates neointimal formation in the early phase after vascular injury in mice: the critical role of the SDF-1-CXCR4 system. Arterioscler Thromb Vasc Biol. 27: 283\u20139. \n                      Find this article online\n                    "
  }, 
  {
    "text": "17.\n              Yokouchi K, Numaguchi Y, Kubota R, Ishii M, Imai H, et al. (2006) l-Caldesmon regulates proliferation and migration of vascular smooth muscle cells and inhibits neointimal formation after angioplasty. Arterioscler Thromb Vasc Biol. 26: 2231\u20137. \n                      Find this article online\n                    "
  }, 
  {
    "text": "18.\n              Kolodgie FD, Burke AP, Farb A, Weber DK, Kutys R, et al. (2002) Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion. Arterioscler Thromb Vasc Biol. 22: 1642\u20138. \n                      Find this article online\n                    "
  }, 
  {
    "text": "19.\n              Yoshioka T, Takahashi M, Shiba Y, Suzuki C, Morimoto H, et al. (2006) Granulocyte colony-stimulating factor (G-CSF) accelerates reendothelialization and reduces neointimal formation after vascular injury in mice. Cardiovasc Res. 70: 61\u20139. \n                      Find this article online\n                    "
  }, 
  {
    "text": "20.\n              Yoshihara S, Kon A, Kudo D, Nakazawa H, Kakizaki I, et al. (2005) A hyaluronan synthase suppressor, 4-methylumbelliferone, inhibits liver metastasis of melanoma cells. FEBS Lett. 579: 2722\u20136. \n                      Find this article online\n                    "
  }, 
  {
    "text": "21.\n              Nakamura T, Takagaki K, Shibata S, Tanaka K, Higuchi T, et al. (1995) Hyaluronic-acid-deficient extracellular matrix induced by addition of 4-methylumbelliferone to the medium of cultured human skin fibroblasts. Biochem Biophys Res Commun. 208: 470\u20135. \n                      Find this article online\n                    "
  }, 
  {
    "text": "22.\n              Fischer JW, Schror K (2007) Regulation of hyaluronan synthesis by vasodilatory prostaglandins. Implications for atherosclerosis. Thromb Haemost. 98: 287\u201395. \n                      Find this article online\n                    "
  }, 
  {
    "text": "23.\n              Zhao L, Lee E, Zukas AM, Middleton MK, Kinder M, et al. (2008) CD44 expressed on both bone marrow-derived and non-bone marrow-derived cells promotes atherogenesis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 28: 1283\u20139. \n                      Find this article online\n                    "
  }, 
  {
    "text": "24.\n              Davis C, Fischer J, Ley K, Sarembock IJ (2003) The role of inflammation in vascular injury and repair. J Thromb Haemost. 1: 1699\u2013709. \n                      Find this article online\n                    "
  }, 
  {
    "text": "25.\n              Cuff CA, Kothapalli D, Azonobi I, Chun S, Zhang Y, et al. (2001) The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation. J Clin Invest. 108: 1031\u201340. \n                      Find this article online\n                    "
  }, 
  {
    "text": "26.\n              Savani RC, Wang C, Yang B, Zhang S, Kinsella MG, et al. (1995) Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM. J Clin Invest. 95: 1158\u201368. \n                      Find this article online\n                    "
  }, 
  {
    "text": "27.\n              Goueffic Y, Guilluy C, Guerin P, Patra P, Pacaud P, et al. (2006) Hyaluronan induces vascular smooth muscle cell migration through RHAMM-mediated PI3K-dependent Rac activation. Cardiovasc Res. 72: 339\u201348. \n                      Find this article online\n                    "
  }, 
  {
    "text": "28.\n              Jain M, He Q, Lee WS, Kashiki S, Foster LC, et al. (1996) Role of CD44 in the reaction of vascular smooth muscle cells to arterial wall injury. J Clin Invest. 98: 877. \n                      Find this article online\n                    "
  }, 
  {
    "text": "29.\n              Kakizaki I, Kojima K, Takagaki K, Endo M, Kannagi R, et al. (2004) A novel mechanism for the inhibition of hyaluronan biosynthesis by 4-methylumbelliferone. J Biol Chem. 279: 33281\u20139. \n                      Find this article online\n                    "
  }, 
  {
    "text": "30.\n              Vigetti D, Rizzi M, Viola M, Karousou E, Genasetti A, et al. (2009) The effects of 4-methylumbelliferone on hyaluronan synthesis, MMP2 activity, proliferation, and motility of human aortic smooth muscle cells. Glycobiology. 19: 537\u201346. \n                      Find this article online\n                    "
  }, 
  {
    "text": "31.\n              Murayama H, Takahashi M, Takamoto M, Shiba Y, Ise H, et al. (2008) Deficiency of tumour necrosis factor-alpha and interferon-gamma in bone marrow cells synergistically inhibits neointimal formation following vascular injury. Cardiovasc Res. 80: 175\u201380. \n                      Find this article online\n                    "
  }, 
  {
    "text": "32.\n              Stacchino C, Spano R, Pettiti A (1983) Spasmolytic activity of some 4-methylumbelliferone derivatives. Boll Chim Farm. 122: 158\u201360. \n                      Find this article online\n                    "
  }, 
  {
    "text": "33.\n              Fontaine L, Grand M, Molho D, Chabert MJ, Boschetti E (1968) [Choleretic, spasmolytic and general pharmacologic activities of 4-methylumbelliferone]. Therapie. 23: 51\u201362. \n                      Find this article online\n                    "
  }
]